Intrinsiqq
Alzamend Neuro Inc. logo

Alzamend Neuro Inc. Financials

ALZN

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 5 of 7 available years
Income Statement
APR 2026
~7.4:1 split
APR 2025
6:1 split
APR 2024
APR 2023
APR 2022
Cost of Revenue–––$0$0
General & Administrative$5$3$3$7$7
Research & Development$4$1$6$7$5
Total Operating Expenses$9$4$10$15$12
Operating Income-$9-$4-$10-$15-$12
Non-Operating
Net Interest Expense-$0-$0-$0-$0-$0
Other Non-Operating Income (Expense)$0$0$0$0$0
EBT (Earnings Before Tax)-$9-$5-$10-$15-$12
Income Tax Expense$0––––
Net Income
Net Income-$9-$5-$10-$15-$12
EPS (Basic)-$2.63-$11.32-$132.33-$206.01-$189.00
EPS (Diluted)-$2.63-$11.32-$132.33-$206.01-$189.00
Weighted Avg Shares (Basic)3.3M450,799676,56597.5M89.1M
Weighted Avg Shares (Diluted)3.3M450,799676,56597.5M89.1M
Shares Outstanding3.3M450,79975,173.88972,236.30865,996.499

Alzamend Neuro (ALZN) financials: revenue, profit and margins

Alzamend Neuro (ALZN) generated about n/a in revenue and -$9 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Alzamend Neuro profitable?+

Alzamend Neuro reported about -$9 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 10 Sept 2026, covering the period ending 31 Jul 2026, as reported to the SEC. Data last refreshed 11 Sept 2026. How this is calculated.

Fiscal year ends Apr.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ALZN

CompareIntrinsic value
LIPOLipella Pharmaceuticals Inc.
$0.00+0.00%25
CARMCarisma Therapeutics Inc.
$0.00+0.00%60
SLNOSoleno Therapeutics Inc
No recent price25
OPKOpko Health Inc.
$1.57-2.48%28
IBIOiBio, Inc.
$0.80+0.01%10
LFVNLifeVantage Corporation
$4.15-15.13%68
PAHCPhibro Animal Health Corporation
$33.29-2.32%57

Spot a number that looks wrong? Check it in ALZN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ALZN

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.